Analyst stock forecast
BioVie Forecast: $5.26 Analyst Target
Direct answer
BioVie's average price target is $5.26.
The target implies +252.7% from the recorded current price, and the consensus rating is none.
The low target implies +235.6%, the high target implies +269.8%, and the range spans 34.2% of the current price.
Forecast evidence checked October 2, 2026.
Get free BioVie email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.49
- Average price target
- $5.26
- High price target
- $5.51
- Low price target
- $5.00
- Low target gap
- +235.6%
- Target upside
- +252.7%
- High target gap
- +269.8%
- Target range width
- 34.2%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- October 2, 2026
- Valid through
- October 9, 2026
Explore related company data
Read the frequently asked questions.
What is BioVie's average price target?
BioVie's verified average price target is $5.26. The target range is $5.00 to $5.51.
How far are BioVie's low and high targets from the recorded price?
The low target implies +235.6%, while the high target implies +269.8%.
How many analysts are included in BioVie's consensus?
The verified consensus includes 2 analysts.
How is BioVie's target upside or downside calculated?
The average target of $5.26 is divided by the recorded price of $1.49, then one is subtracted to produce +252.7%. This does not guarantee a future return.
When was BioVie's analyst forecast verified?
The data was verified on 2026-10-02. The dataset is valid through 2026-10-09.